Development of alpha-tocopherol nanomicellar formulation using polyethylene glycol monostearate for the oxidative stress-related disease

○Yuka Hokimoto

[29P01-275S] Development of alpha-tocopherol nanomicellar formulation using polyethylene glycol monostearate for the oxidative stress-related disease

○Yuka Hokimoto¹, Kengo Banshoya¹, Masaya Kubota¹, Hikaru Kimura¹, Nanami Toba¹, Chiaki Fujita¹, Terukazu Masuda¹, Tetsuya Nakamura¹, Tetsuro Tanaka¹, Yoshiharu Kaneo¹ (1. Fukuyama University, Faculty of Pharmacy and Pharmaceutical Sciences)

A password that applicants have been notified of is required to view abstracts.
If you are a participant and need to confirm the password, please contact us by e-mail about which annual meeting you would like to know the password for to view abstracts.
We will reply after confirming that you were a participant.
Thank you for your understanding.

Presentation information

[29P01] ターゲティング/がん治療DDS
製剤の設計・製造（固形・注射剤・液剤）/新規剤形

[29P01-275S] Development of alpha-tocopherol nanomicellar formulation using polyethylene glycol monostearate for the oxidative stress-related disease

Password

Presentation information

[29P01] ターゲティング/がん治療DDS製剤の設計・製造（固形・注射剤・液剤）/新規剤形

[29P01-275S] Development of alpha-tocopherol nanomicellar formulation using polyethylene glycol monostearate for the oxidative stress-related disease

Password

[29P01] ターゲティング/がん治療DDS
製剤の設計・製造（固形・注射剤・液剤）/新規剤形